查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589747

內視鏡逆行性造影市場：按產品、程序和最終用戶 - 全球預測 2025-2030

Endoscopic Retrograde Cholangiopancreatography Market by Product (Endoscopes, Endotherapy Devices, Energy Devices), Procedure (Biliary Dilatation, Biliary Sphincterotomy, Biliary Stenting), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年內視鏡逆行性造影市場價值為19.1億美元，預計2024年將達20.5億美元，複合年成長率為7.59%，到2030年預計將達32億美元。

內視鏡逆行性造影(ERCP) 是一種結合內視鏡檢查和螢光鏡檢查來診斷和治療膽管和胰管系統疾病的專業技術。它對於膽結石、狹窄、囊腫、癌症和其他阻塞等症狀尤其必要，是胃腸病學的重要檢查。 ERCP 主要在醫院和專科診所進行，為需要全面消化器官系統評估的患者提供服務。隨著胰臟和膽道疾病的盛行率不斷增加，市場受到人口老化和早期診斷和治療方案意識增強的影響。微創技術和增強成像解決方案的開發等技術進步正在推動顯著成長。此外，由於醫療基礎設施的改善和醫療旅遊業的擴張，亞洲和拉丁美洲的新興市場提供了巨大的商機。然而，其局限性包括成本高、需要訓練有素的專業人員以及術後胰臟炎等併發症的風險，這可能會阻礙廣泛使用。挑戰包括嚴格的法規環境和各地區的報銷問題。為了利用市場機會，公司應該專注於技術創新，例如設備小型化、開拓更準確的診斷程序以及與醫療保健提供者合作以提高程序的安全性和有效性。此外，可以透過促進提高從業人員技能的教育計劃來擴大 ERCP 的採用。隨著公司尋求擴大其技術組合和地理影響力，市場競爭變得越來越激烈，策略聯盟和合併也變得越來越普遍。人工智慧和機器學習的創新有可能進一步個性化診斷和治療，使該領域成為一個有前途的研究領域。總體而言，如果相關人員有效克服障礙並利用醫療技術和手術實踐的尖端創新，ERCP 市場有望成長。

主要市場統計
基準年[2023] 19.1億美元
預測年份 [2024] 20.5億美元
預測年份 [2030] 32億美元
複合年成長率（%） 7.59%

市場動態：快速發展的內視鏡逆行性造影市場的關鍵市場洞察

供需的動態交互作用正在改變內視鏡逆行性造影市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 胃腸道和慢性膽道疾病的盛行率增加
    • 全球醫療基礎設施改善導致醫療保健支出增加
    • 對微創手術的偏好日益增加，加上消費者對先進內視鏡技術的認知不斷增強
  • 市場限制因素
    • 內視鏡逆行性造影設備的高成本
  • 市場機會
    • 投入巨額研發活動以推進內視鏡手術
    • 內視鏡逆行性造影解決方案的引入正在迅速增加，各國政府正在採取積極措施。
  • 市場挑戰
    • 全球缺乏熟練的專業人員和訓練有素的內視鏡醫師

波特五力：駕馭內視鏡逆行造影市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解內視鏡逆行性造影市場的外部影響

外部宏觀環境因素在塑造內視鏡逆行性造影市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解內視鏡逆行性造影市場的競爭格局

內視鏡逆行性造影市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，以應對日益激烈的競爭。

FPNV 定位矩陣內視鏡逆行性造影市場供應商的績效評估

FPNV定位矩陣是評估內視鏡逆行性造影市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了內視鏡逆行性造影市場的成功之路

對於希望加強在全球市場的影響力的公司來說，內視鏡逆行性造影市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 胃腸道和慢性膽道疾病的盛行率增加
      • 增加醫療成本並加強全球醫療基礎設施
      • 對微創手術的偏好日益增加，消費者對先進內視鏡技術的認知不斷增強
    • 抑制因素
      • 內視鏡逆行性造影設備的高成本
    • 機會
      • 重大研發活動涉及大量投資以推進內視鏡手術
      • 由於政府的積極行動，內視鏡逆行造影解決方案的採用正在迅速增加
    • 任務
      • 全世界都缺乏熟練的專業人員和訓練有素的內視鏡醫師。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章內視鏡逆行性造影市場：依產品

  • 內視鏡
  • 內視鏡治療裝置
    • 氣球
    • 籃子
    • 插管
    • 導管
    • 鉗子
    • 導管導引線
    • 碎石機
    • 勒除器
    • 括約肌切開術
    • 支架
  • 能源裝置
  • 視覺化系統

第7章依手術方式分類的內視鏡逆行性造影市場

  • 膽管擴張
  • 膽管括約肌切開術
  • 膽管支架
  • 胰管擴張
  • 置入術
  • 胰臟括約肌切開術

第8章內視鏡逆行性造影市場：依最終用戶分類

  • 門診手術中心及診所
  • 醫院

第9章美洲內視鏡逆行性造影市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區內視鏡逆行造影市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲內視鏡逆行性造影市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • KARL STORZ SE & Co. KG
  • Machida Endoscope Co., Ltd
  • Medi-Globe GmbH
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Olympus Corporation
  • Ottomed Endoscopy
  • PENTAX Medical
  • Richard Wolf GmbH
  • Smith & Nephew PLC
  • STERIS
  • Stryker Corporation
Product Code: MRR-5A2C6AA6657B

The Endoscopic Retrograde Cholangiopancreatography Market was valued at USD 1.91 billion in 2023, expected to reach USD 2.05 billion in 2024, and is projected to grow at a CAGR of 7.59%, to USD 3.20 billion by 2030.

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a specialized technique combining endoscopy and fluoroscopy to diagnose and treat conditions of the biliary or pancreatic ductal systems. The procedure is particularly necessary for conditions like gallstones, strictures, cysts, cancer, and other blockages, making it indispensable in gastroenterology. ERCP is applied predominantly within hospitals and specialized clinics, serving patients who require comprehensive digestive system evaluations. Amidst the increasing prevalence of pancreatic and biliary diseases, the market is influenced by an aging population and growing awareness about early diagnosis and treatment options. Technological advancements, such as the development of minimally invasive techniques and enhanced imaging solutions, drive significant growth. Moreover, emerging markets in Asia and Latin America present substantial opportunities due to improving healthcare infrastructure and expanding medical tourism. However, the market encounters limitations such as high costs, the need for skilled professionals, and the risk of complications like pancreatitis post-procedure, which might deter its adoption. Challenges include stringent regulatory environments and reimbursement issues in various regions. To capitalize on market opportunities, businesses should focus on innovations in equipment miniaturization, development of more accurate diagnostic procedures, and collaborations with healthcare providers to improve procedural safety and efficacy. Moreover, fostering educational programs to enhance practitioner skills can broaden the adoption of ERCP. The market tends towards competitive consolidation, with strategic alliances and mergers becoming more frequent for firms aiming to expand their technology portfolios and geographic presence. Innovations in artificial intelligence and machine learning could further personalize diagnosis and treatment, making this a promising area for research. Overall, the ERCP market is poised for growth, provided stakeholders navigate barriers effectively and leverage cutting-edge innovations in medical technology and procedural practices.

KEY MARKET STATISTICS
Base Year [2023] USD 1.91 billion
Estimated Year [2024] USD 2.05 billion
Forecast Year [2030] USD 3.20 billion
CAGR (%) 7.59%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of gastrointestinal and chronic biliary disorders
    • Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
    • Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
  • Market Restraints
    • High costs associated with endoscopic retrograde cholangiopancreatography devices
  • Market Opportunities
    • Significant research and development activities with heavy investments for advancement of endoscopic procedures
    • Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
  • Market Challenges
    • Scarcity of skilled professionals and trained endoscopists across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Endoscopic Retrograde Cholangiopancreatography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endoscopic Retrograde Cholangiopancreatography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endoscopic Retrograde Cholangiopancreatography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endoscopic Retrograde Cholangiopancreatography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endoscopic Retrograde Cholangiopancreatography Market

A detailed market share analysis in the Endoscopic Retrograde Cholangiopancreatography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endoscopic Retrograde Cholangiopancreatography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endoscopic Retrograde Cholangiopancreatography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endoscopic Retrograde Cholangiopancreatography Market

A strategic analysis of the Endoscopic Retrograde Cholangiopancreatography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endoscopic Retrograde Cholangiopancreatography Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd, Medi-Globe GmbH, Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Ottomed Endoscopy, PENTAX Medical, Richard Wolf GmbH, Smith & Nephew PLC, STERIS, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Endoscopic Retrograde Cholangiopancreatography Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Endoscopes, Endotherapy Devices, Energy Devices, and Visualization Systems. The Endotherapy Devices is further studied across Balloons, Baskets, Cannulas, Catheters, Forceps, Guiding Wires, Lithotripter, Snares, Sphincterotomes, and Stents.
  • Based on Procedure, market is studied across Biliary Dilatation, Biliary Sphincterotomy, Biliary Stenting, Pancreatic Duct Dilatation, Pancreatic Duct Stenting, and Pancreatic Sphincterotomy.
  • Based on End-User, market is studied across Ambulatory Surgery Centres & Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of gastrointestinal and chronic biliary disorders
      • 5.1.1.2. Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
      • 5.1.1.3. Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with endoscopic retrograde cholangiopancreatography devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant research and development activities with heavy investments for advancement of endoscopic procedures
      • 5.1.3.2. Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals and trained endoscopists across the globe
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endoscopic Retrograde Cholangiopancreatography Market, by Product

  • 6.1. Introduction
  • 6.2. Endoscopes
  • 6.3. Endotherapy Devices
    • 6.3.1. Balloons
    • 6.3.2. Baskets
    • 6.3.3. Cannulas
    • 6.3.4. Catheters
    • 6.3.5. Forceps
    • 6.3.6. Guiding Wires
    • 6.3.7. Lithotripter
    • 6.3.8. Snares
    • 6.3.9. Sphincterotomes
    • 6.3.10. Stents
  • 6.4. Energy Devices
  • 6.5. Visualization Systems

7. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure

  • 7.1. Introduction
  • 7.2. Biliary Dilatation
  • 7.3. Biliary Sphincterotomy
  • 7.4. Biliary Stenting
  • 7.5. Pancreatic Duct Dilatation
  • 7.6. Pancreatic Duct Stenting
  • 7.7. Pancreatic Sphincterotomy

8. Endoscopic Retrograde Cholangiopancreatography Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centres & Clinics
  • 8.3. Hospitals

9. Americas Endoscopic Retrograde Cholangiopancreatography Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun Melsungen AG
  • 2. Becton, Dickinson and Company
  • 3. Boston Scientific Corporation
  • 4. CONMED Corporation
  • 5. Cook Group Incorporated
  • 6. Fujifilm Holdings Corporation
  • 7. Johnson & Johnson Services, Inc.
  • 8. KARL STORZ SE & Co. KG
  • 9. Machida Endoscope Co., Ltd
  • 10. Medi-Globe GmbH
  • 11. Medtronic PLC
  • 12. Merit Medical Systems, Inc.
  • 13. Olympus Corporation
  • 14. Ottomed Endoscopy
  • 15. PENTAX Medical
  • 16. Richard Wolf GmbH
  • 17. Smith & Nephew PLC
  • 18. STERIS
  • 19. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET RESEARCH PROCESS
  • FIGURE 2. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET DYNAMICS
  • TABLE 7. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BASKETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY FORCEPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LITHOTRIPTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SNARES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY DILATATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SPHINCTEROTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY STENTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT DILATATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT STENTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SPHINCTEROTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGERY CENTRES & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 202. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2023